GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » D&D Pharmatech Inc (XKRX:347850) » Definitions » Other Gross PPE

D&D Pharmatech (XKRX:347850) Other Gross PPE : ₩11,202 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is D&D Pharmatech Other Gross PPE?

D&D Pharmatech's Other Gross PPE for the quarter that ended in Dec. 2024 was ₩11,202 Mil.

D&D Pharmatech's quarterly Other Gross PPE declined from Jun. 2024 (₩10,786 Mil) to Sep. 2024 (₩10,308 Mil) but then increased from Sep. 2024 (₩10,308 Mil) to Dec. 2024 (₩11,202 Mil).

D&D Pharmatech's annual Other Gross PPE increased from Dec. 2022 (₩5,329 Mil) to Dec. 2023 (₩10,565 Mil) and increased from Dec. 2023 (₩10,565 Mil) to Dec. 2024 (₩11,202 Mil).


D&D Pharmatech Other Gross PPE Historical Data

The historical data trend for D&D Pharmatech's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

D&D Pharmatech Other Gross PPE Chart

D&D Pharmatech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial 6,094.34 10,137.06 5,328.97 10,565.40 11,201.72

D&D Pharmatech Quarterly Data
Dec18 Dec19 Dec20 Dec21 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 11,264.57 10,565.40 10,785.84 10,307.71 11,201.72

D&D Pharmatech Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


D&D Pharmatech Business Description

Traded in Other Exchanges
N/A
Address
4th floor, 24, Pangyo-ro 255beon-gil, Bundang-gu, Gyeonggi-do, Sampyeong-dong, I&C Building, Seongnam-si, KOR
D&D Pharmatech Inc is a company that comprises of experts in the field of bio-new drug research and development and technology commercialization, including basic scientists in the pharmaceutical biofield, manufacturing quality control (CMC) experts, and clinical development and technology transfer experts. Other business areas include the development of positron emission tomography (PET) imaging biomarkers conducted by Precision Molecular Inc. a 100% subsidiary, and single-cell sequencing related to degenerative brain diseases conducted by Valted Seq, Inc. The company utilizes drug delivery technologies such as PEGylation technology, which helps extend the administration interval using PEG and various chemicals, and platform technology that converts injectable drugs into oral preparations.

D&D Pharmatech Headlines

No Headlines